PPAR 작용 조절 질환의 예방, 개선 또는 치료용 조성물
    13.
    发明公开
    PPAR 작용 조절 질환의 예방, 개선 또는 치료용 조성물 有权
    用于预防,改善或治疗由PPAR治疗控制的疾病的组合物

    公开(公告)号:KR1020130083427A

    公开(公告)日:2013-07-22

    申请号:KR1020130080351

    申请日:2013-07-09

    Abstract: PURPOSE: A composition for preventing, treating, or alleviating peroxisome proliferator-activated receptor (PPAR) action regulatory diseases is provided to promote PPAR activation and to prevent, treat, or alleviate the diseases including obesity, metabolic diseases, and cardiovascular diseases. CONSTITUTION: A pharmaceutical composition for preventing or treating PPAR action regulator diseases selected among diabetes, obesity, hyperinsulinemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, artery scleroma, and combination thereof contains a compound of chemical formula 1 or 2, or a pharmaceutically acceptable salt or a solvate thereof. A composition for health functional foods for preventing or treating the diseases contains the compound, the pharmaceutically acceptable salt, or the solvate.

    Abstract translation: 目的:提供一种预防,治疗或减轻过氧化物酶体增殖物激活受体(PPAR)作用调节性疾病的组合物,用于促进PPAR活化并预防,治疗或减轻包括肥胖,代谢疾病和心血管疾病在内的疾病。 构成:用于预防或治疗选自糖尿病,肥胖症,高胰岛素血症,高脂血症,高胆固醇血症,高甘油三酯血症,动脉硬化及其组合的PPAR活性调节剂疾病的药物组合物含有化学式1或2的化合物或其药学上可接受的盐或 其溶剂合物。 用于预防或治疗疾病的健康功能性食品的组合物含有化合物,药学上可接受的盐或溶剂合物。

    파낙스속 식물 추출물의 마이얄형 갈색화 반응 생성물을 포함하는 신장질환의 예방, 개선 또는 치료용 조성물
    14.
    发明公开
    파낙스속 식물 추출물의 마이얄형 갈색화 반응 생성물을 포함하는 신장질환의 예방, 개선 또는 치료용 조성물 有权
    用于预防,改善或治疗包含PANAX SPP的MAABARD BROWNING REACTION产品的肾病的组合物。 植物提取物

    公开(公告)号:KR1020130082048A

    公开(公告)日:2013-07-18

    申请号:KR1020120031828

    申请日:2012-03-28

    Abstract: PURPOSE: A therapeutic composition is provided to be able to be effectively used in prevention, alleviation or treatment of kidney diseases as the Panax species plant extract or the product of the Maillard type browning reaction with glucose amino acid have an excellent removal ability of active oxygen, and remarkably excellent activation to suppress damage of kidney epithelial cell due to the oxidative stress. CONSTITUTION: A pharmaceutical composition for prevention or treatment of kidney diseases comprises ginsenoside Re, Panax species plant extract including ginsenoside Re, or the product of the Maillard browning reaction obtained by reacting ginsenoside-originated saccharide with amino acid at 100-130deg.C, as an active ingredient. A composition for health functional food for prevention or alleviation of kidney diseases includes ginsenoside Re, Panax species plant extract including ginsenoside Re, or the product of the Maillard browning reaction obtained by reacting ginsenoside-originated saccharide with amino acid at 100-130deg.C, as an active ingredient. The Panax species plant is Korean ginseng, Panax quinquefolius, Panax notoginseng, Japanse seng, Panax trifolium, Himalayan ginseng, Panax vietnamensis, their cultured root, or their combination. [Reference numerals] (AA) Ginsenoside Re; (BB) Ginsenoside Rg_2; (CC) Dehydration reaction; (DD) Ginsenoside Rg_6; (EE) Ginsenoside F_4; (FF) Separated glucose + Glycine; (GG) Maillard browning reaction

    Abstract translation: 目的:提供治疗组合物,以能够有效地用于预防,减轻或治疗肾脏疾病,因为人参植物提取物或美拉德型褐变反应与葡萄糖氨基酸的产物具有优异的活性氧去除能力 ,并且显着优异的活化以抑制由于氧化应激引起的肾上皮细胞的损伤。 构成:用于预防或治疗肾脏疾病的药物组合物包括人参皂甙Re,人参皂苷Re的人参植物提取物,或将人参皂甙起源的糖与氨基酸在100-130℃下反应获得的美拉德褐变反应的产物,作为 活性成分。 用于预防或减轻肾脏疾病的健康功能食品的组合物包括人参皂苷Re,人参皂苷Re的人参植物提取物,或通过使人参皂甙起源的糖与氨基酸在100-130℃反应而获得的美拉德褐变反应的产物, 作为活性成分。 人参植物是韩国人参,三七,三七,日本人,三七,喜马拉雅,人参,培养根或其组合。 (AA)人参皂甙Re; (BB)人参皂甙Rg_2; (CC)脱水反应; (DD)人参皂甙Rg_6; (EE)人参皂甙F_4; (FF)分离葡萄糖+甘氨酸; (GG)美拉德褐变反应

    마이크로웨이브 조사에 의해 진세노사이드 알지3, 알지5 및 알케이1의 함량비율이 증가된 파낙스속 식물 추출물, 그 제조방법, 및 그 가공 파낙스속 식물 추출물을 포함하는 조성물
    15.
    发明授权
    마이크로웨이브 조사에 의해 진세노사이드 알지3, 알지5 및 알케이1의 함량비율이 증가된 파낙스속 식물 추출물, 그 제조방법, 및 그 가공 파낙스속 식물 추출물을 포함하는 조성물 有权
    PANAX SPP。 具有通过微波辐照生产的茚满酮RG3,RG5和RK1的增加的含量的植物提取物,其制备方法和包含其的组合物

    公开(公告)号:KR101260047B1

    公开(公告)日:2013-05-06

    申请号:KR1020130007651

    申请日:2013-01-23

    CPC classification number: A61K36/258 A61K31/704 A61K2236/37 A61K2300/00

    Abstract: PURPOSE: A Panax species plant extract having the increased content of ginsenoside Rg5 and Rk1 by microwave irradiation, a manufacturing method thereof, and a composition containing the processed Panax species plant extract are provided to enhance an effect of Rg5 and Rk1 compared to an extract by simple thermal-processing. CONSTITUTION: A manufacturing method of a Panax species plant extract comprises: a step of irradiating Panax species plants or an extract thereof with microwaves. The Panax species plant or the extract contains more than 90% of Rg3, Rk1, and Rg5 to the weight of ginsenoside Rb1, Rc, Rb2, Rd, Rg3, Rk1 and Rg5. The microwave irradiation is performed at 150-190 deg. C for 30-90 minutes while pressurizing. The microwave irradiation is performed under 2-100 atmospheric pressure. The Panax species plant extract has a ratio of ginsenoside (Rg5+Rk1)/(Rg3) of 2 or greater. [Reference numerals] (AA) Voltage(mv); (BB) Time(minutes)

    Abstract translation: 目的:提供通过微波照射提高人参皂甙Rg5和Rk1含量增加的Panax种植物提取物,其制备方法和含有加工的Panax种植物提取物的组合物,以提高Rg5和Rk1与提取物相比的作用 简单的热处理。 构成:人参植物提取物的制造方法包括:将微生物种类植物或其提取物照射到微波的步骤。 人参植物或提取物含有人参皂甙Rb1,Rc,Rb2,Rd,Rg3,Rk1和Rg5重量的Rg3,Rk1和Rg5的90%以上。 微波照射在150-190度进行。 C加压30-90分钟。 微波照射在2-100大气压下进行。 人参植物提取物的人参皂甙(Rg5 + Rk1)/(Rg3)的比值为2以上。 (附图标记)(AA)电压(mv); (BB)时间(分钟)

    다중약물내성 암세포에 유용한 항암제
    16.
    发明授权
    다중약물내성 암세포에 유용한 항암제 有权
    抗癌药物对多药耐药癌细胞有效

    公开(公告)号:KR100961688B1

    公开(公告)日:2010-06-09

    申请号:KR1020080018323

    申请日:2008-02-28

    Abstract: 본 발명은 다중약물내성 암세포에 유용한 항암제에 관한 것으로서, 구체적으로 상기 3-(2-벤족사졸릴)-7-(디에틸아미노)쿠마린[3-(2-Benzoxazolyl)- 7-(diethylamino)Coumarin]을 유효성분으로 함유하는 기존 항암제에 대해 다중약물내성을 나타내는 암세포에 대한 우수한 사멸효과를 제공하는 조성물에 관한 것이다. 본 발명의 조성물은 항암제에 내성을 나타내는 다중약물내성(Multidrug resistance, MDR) 세포에서 보이는 항암제내성을 극복할 수 있어서 정상암세포는 물론 MDR을 나타내는 세포에서도 항암효과가 있으므로, 약학적으로 유용한 항암제로 사용될 수 있다.
    3-(2-벤족사졸릴)-7-(디에틸아미노)쿠마린, 다중약물내성

    블루밍샐리 추출물을 유효성분으로 함유하는 조성물
    17.
    发明公开
    블루밍샐리 추출물을 유효성분으로 함유하는 조성물 有权
    包含作为活性成分的化合物促凝剂提取物的组合物

    公开(公告)号:KR1020090041533A

    公开(公告)日:2009-04-29

    申请号:KR1020070107087

    申请日:2007-10-24

    CPC classification number: A61K36/185

    Abstract: A composition containing Chamaenerion angustifolium extract with anti-wrinkle and antioxidant activities is provided to show wrinkle and elasticity improvement by the Chamaenerion angustifolium extracts having effects of inhibiting type I collagenase and AP-1. A composition containing Chamaenerion angustifolium extract with anti-wrinkle and antioxidant activities comprises Chamaenerion angustifolium extract obtained by adding water and alcohol or a mixed solvent thereof. The Chamaenerion angustifolium extract inhibits inflammation and improves skin elasticity. The composition has a formulation of external skin application. The composition represents cosmetics or health foods. The Chamaenerion angustifolium extract is an active ingredient in the composition.

    Abstract translation: 提供了具有抗皱和抗氧化活性的含有Chamaenerion angustifolium提取物的组合物,以显示具有抑制I型胶原酶和AP-1的作用的Chamaenerion angustifolium提取物的皱纹和弹性改善。 具有抗皱和抗氧化活性的含有尖角鳗提取物的组合物包括通过加入水和醇或其混合溶剂获得的Challenerion angustifolium提取物。 Chamaenerion angustifolium提取物抑制炎症并改善皮肤弹性。 该组合物具有外用皮肤应用的配方。 组合物代表化妆品或保健食品。 Chamaenerion angustifolium提取物是组合物中的活性成分。

    오틸리아 추출물을 유효성분으로 함유하는 조성물
    18.
    发明公开
    오틸리아 추출물을 유효성분으로 함유하는 조성물 有权
    包含ORTILIA SECUNDA提取物作为活性成分的组合物

    公开(公告)号:KR1020090041531A

    公开(公告)日:2009-04-29

    申请号:KR1020070107085

    申请日:2007-10-24

    Abstract: A composition containing Ortilia secunda extracts is provided to show wrinkle and elasticity improvement by the Ortilia secunda extracts having effects of inhibiting type I collagenase and AP-1 and increasing generation of collagen while suppressing decomposition of the collagen. A composition for wrinkle improvement comprises Ortilia secunda extracts obtained by adding water and C1-C4 low alcohol such as ethanol and methanol or mixed solvents thereof. The Ortilia secunda extracts are active ingredients in the composition for wrinkle improvement. The Ortilia secunda extracts eliminate radicals. The composition has a formulation of external skin application. The composition for wrinkle improvement represents antioxidant.

    Abstract translation: 提供含有Ortilia secunda提取物的组合物,以显示具有抑制I型胶原酶和AP-1的作用的Ortilia secunda提取物的皱纹和弹性改善,并增加胶原蛋白的产生,同时抑制胶原蛋白的分解。 用于皱纹改良的组合物包括通过加入水和C1-C4低级醇如乙醇和甲醇或其混合溶剂获得的Ortilia secunda提取物。 Ortilia secunda提取物是用于皱纹改善的组合物中的活性成分。 Ortilia secunda提取物消除自由基。 该组合物具有外用皮肤应用的配方。 用于皱纹改善的组合物表示抗氧化剂。

    드라코세팔룸 포에티둠 추출물, 고두자 추출물 또는 이의 분획물을 포함하는 항균용 조성물
    20.
    发明公开
    드라코세팔룸 포에티둠 추출물, 고두자 추출물 또는 이의 분획물을 포함하는 항균용 조성물 有权
    含有DRACOCEPHALUM FOETIDIUM EXTRACTS的抗真菌和抗真菌组合物,SOPHORA ALOPECUROIDES提取物或其分类

    公开(公告)号:KR1020070092033A

    公开(公告)日:2007-09-12

    申请号:KR1020060021934

    申请日:2006-03-08

    Abstract: An extract of Dracocephalum foetidum and an extract of Sophora alopecuroides are provided to be used as an antibacterial composition for washing and sterilizing the skin surface, prevent the decay and the poisoning of the food, and periodontal diseases, and be used as a natural antibacterial agent for a filter of an air purifying product by having antibacterial activity on bacteria and fungi of skin surface, bacteria causing decay of foods and food-poisoning, Streptococcus Mutans and antibiotics resistant bacteria. An antibacterial composition comprises an extract of Dracocephalum foetidum which is a refined oil ingredient of the Dracocephalum foetidum or an extract of Sophora alopecuroides which is prepared by using a solvent such as water, alcohol, hexane, methylene chloride, ethyl acetate and a mixture thereof.

    Abstract translation: 提供杜鹃花提取物和苦参提取物作为抗菌组合物,用于对皮肤表面进行洗涤和灭菌,防止食物的腐烂和中毒,以及牙周病,并用作天然抗菌剂 通过对皮肤表面的细菌和真菌具有抗菌活性,引起食物腐烂和食物中毒的细菌,变形链球菌和抗生素抗性细菌,对空气净化产品的过滤器。 一种抗菌组合物,其特征在于,含有作为茯苓的精制油成分的Dracocephalum foetidum的提取物或通过使用溶剂如水,醇,己烷,二氯甲烷,乙酸乙酯及其混合物制备的苦参甙提取物。

Patent Agency Ranking